Cardiomyopathy Research Protocols
Judge, Daniel
- OPT-CHF: This is a trial evaluating a new drug called Oxyprim in patients with NYHA Class III-IV heart failure symptoms with an ejection fraction < 40%.
- REVIVE study: This is a trial evaluating the use of the investigational drug Levosimendan in patients admitted with decompensated heart failure and an ejection fraction < 35%.
Hare, Joshua
- ESSENTIAL trial: This is a trial evaluating the investigational drug Enoximone in patients with NYHA Class III-IV heart failure symptoms with an ejection fraction < 30%.
Wittstein, Lon
- STICH: This is an NIH sponsored trial evaluating medical versus surgical therapy in patients with ischemic heart disease and symptomatic heart failure.
